← All trials
NCT06113913
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2024
- Primary completion
- Jan 31, 2026
- Completion date
- Sep 30, 2026
- First posted
- Nov 2, 2023
- Last posted
- Nov 2, 2023
- Enrollment
- 310
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZWLead sponsor
- CelltrionCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.